Advitech Inc.

Quebec – Quebec City – Québec

Corporation

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Corporation

active

Advitech is a health sciences and technology company with a mission to discover and commercialize proprietary and evidence-based natural products.
Its main platform, XP-828L, is a patented technology to extract growth factors and other bioactive peptides from milk proteins. These growth factors and peptides can modulate the immune system and therefore play a role in the prevention of Immune Mediated and Inflammatory disorders such as Psoriasis.
Advitech has recently introduced in several markets Dermylexâ„¢ for mild to moderate psoriasis.
Country of Ownership: Canada
Year Established: 1996
Exporting: Yes
Primary Industry (NAICS): 541710 - Research and Development in the Physical, Engineering and Life Sciences
Primary Business Activity: Manufacturer / Processor / Producer
Total Sales ($CDN): $500,000 to $999,999
Export Sales ($CDN): $200,000 to $499,999
Number of Employees: 15

Products:
Dermylex

Technology:
Technological platform for isolation of growth factors and bioactives peptides from dairy products like whey.

Sector:
Distribution of Employees
80% headquarters
20% laboratories
Key / Major Clients: Jamieson Laboratories (Canada)
Thorne Research / DNP Worldwide (USA)
IPrad Santé (France and Belgique)
Enbio Life Biotechnology (Taiwan)

No associations

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian companies and directors. Rate them and share your experience with other people.

Rating

Advitech Inc. does not yet have a rating. At this time, there are no reviews or comments for this company.

If you have personal experience with Advitech Inc., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Advitech Inc. will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-COD-O-10818

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.